Hillsdale Investment Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-280	Closed	-$144K	–	527
2016 Q4	$144K	Buy	+280	New	+$144K	0.03%	297